Index S&P 500
P/E 15.49
EPS (ttm) 7.98
Insider Own 0.67%
Shs Outstand 1.74B
Perf Week -6.32%
Market Cap 215.17B
Forward P/E 21.77
EPS next Y 5.68
Insider Trans -4.89%
Shs Float 1.73B
Perf Month -6.51%
Enterprise Value 221.82B
PEG 1.49
EPS next Q 1.31
Inst Own 79.93%
Short Float 1.12%
Perf Quarter -4.65%
Income 13.91B
P/S 4.99
EPS this Y 10.36%
Inst Trans 2.41%
Short Ratio 3.01
Perf Half Y 11.31%
Sales 43.11B
P/B 4.41
EPS next Y 10.25%
ROA 17.45%
Short Interest 19.43M
Perf YTD 9.34%
Book/sh 28.05
P/C 31.44
EPS next 5Y 10.42%
ROE 30.66%
52W High 141.23 -12.43%
Perf Year 20.40%
Cash/sh 3.93
P/FCF 32.32
EPS past 3/5Y 24.73% 29.98%
ROIC 22.61%
52W Low 99.71 24.03%
Perf 3Y 16.44%
Dividend Est. 2.40 (1.94%)
EV/EBITDA 21.43
Sales past 3/5Y -0.88% 5.63%
Gross Margin 58.40%
Volatility 2.69% 2.08%
Perf 5Y 32.85%
Dividend TTM 2.32 (1.88%)
EV/Sales 5.15
EPS Y/Y TTM 139.98%
Oper. Margin 17.62%
ATR (14) 3.18
Perf 10Y 147.69%
Dividend Ex-Date Jul 15, 2025
Quick Ratio 1.27
Sales Y/Y TTM 5.85%
Profit Margin 32.28%
RSI (14) 31.91
Recom 1.90
Dividend Gr. 3/5Y 7.17% 11.16%
Current Ratio 1.78
EPS Q/Q 37.19%
SMA20 -6.87%
Beta 0.71
Target Price 143.17
Payout 29.33%
Debt/Eq 0.27
Sales Q/Q 7.37%
SMA50 -7.07%
Rel Volume 3.03
Prev Close 120.51
Employees 114000
LT Debt/Eq 0.26
Earnings Jul 17 BMO
SMA200 -1.19%
Avg Volume 6.45M
Price 123.67
IPO Mar 01, 1937
Option/Short Yes / Yes
EPS/Sales Surpr. 0.33% 0.45%
Trades
Volume 19,570,105
Change 2.62%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-18-25 Upgrade
Jefferies
Hold → Buy
$145
Jun-16-25 Initiated
Leerink Partners
Market Perform
$143
Oct-08-24 Initiated
Oppenheimer
Outperform
$130
Sep-19-24 Initiated
Piper Sandler
Overweight
$131
Jul-30-24 Downgrade
Edward Jones
Buy → Hold
May-30-24 Initiated
Goldman
Buy
$121
Jul-21-23 Upgrade
Wolfe Research
Underperform → Peer Perform
May-30-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$112
Apr-20-23 Reiterated
Wolfe Research
Underperform
$107 → $103
Apr-20-23 Reiterated
UBS
Buy
$117 → $130
Apr-20-23 Reiterated
Raymond James
Outperform
$116 → $123
Apr-20-23 Reiterated
JP Morgan
Overweight
$118 → $122
Apr-20-23 Reiterated
Bernstein
Outperform
$132 → $133
Apr-20-23 Reiterated
Barclays
Overweight
$125 → $127
Mar-29-23 Initiated
UBS
Buy
$117
Oct-26-22 Initiated
Mizuho
Neutral
$105
Oct-18-22 Initiated
Barclays
Overweight
$118
Oct-12-22 Initiated
Jefferies
Hold
$110
Jul-06-22 Initiated
Wolfe Research
Underperform
$95
Mar-02-22 Resumed
BofA Securities
Buy
$140
Show Previous Ratings
Jul-18-25 09:14PM
12:34PM
11:01AM
09:47AM
09:40AM
09:38AM
Loading…
09:38AM
09:35AM
09:03AM
03:08AM
01:31AM
Jul-17-25 08:08PM
08:07PM
04:38PM
04:10PM
(Investor's Business Daily)
02:43PM
01:21PM
Loading…
01:21PM
12:59PM
11:29AM
11:13AM
11:06AM
10:48AM
10:11AM
09:30AM
08:52AM
(Investor's Business Daily)
08:40AM
08:16AM
08:13AM
08:05AM
(The Wall Street Journal)
07:44AM
07:37AM
(Associated Press Finance)
07:33AM
Loading…
07:33AM
07:30AM
06:05AM
05:08AM
(The Wall Street Journal)
03:46AM
(The Wall Street Journal)
Jul-16-25 07:00PM
06:02PM
05:45PM
(The Wall Street Journal)
04:48PM
11:40AM
09:52AM
08:19AM
04:07AM
03:43AM
(The Wall Street Journal)
03:43AM
(The Wall Street Journal)
12:09AM
Jul-15-25 11:03PM
05:52PM
(The Wall Street Journal)
04:55PM
09:02AM
08:45AM
Jul-14-25 04:45PM
(The Wall Street Journal)
09:15AM
08:29AM
04:17AM
Jul-13-25 07:51AM
Jul-12-25 06:40AM
Jul-11-25 07:10PM
06:00PM
09:46AM
Jul-10-25 04:25PM
10:00AM
08:21AM
08:18AM
07:28AM
Jul-09-25 09:09AM
08:50AM
08:29AM
04:43AM
01:30AM
Jul-08-25 08:31AM
08:00AM
Jul-07-25 08:17AM
08:00AM
Jul-06-25 08:45AM
Jul-04-25 09:30AM
04:01AM
02:43AM
Jul-03-25 08:50AM
Jul-02-25 06:00PM
12:00PM
10:01AM
09:40AM
09:35AM
09:00AM
Jul-01-25 04:42PM
(Investor's Business Daily)
02:41PM
12:26PM
(Investor's Business Daily)
09:00AM
07:01AM
Jun-30-25 06:46AM
06:22AM
Jun-28-25 05:49AM
01:27AM
Jun-26-25 06:00PM
01:26PM
11:40AM
09:00AM
08:45AM
Jun-25-25 03:08PM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Blount Sally E. Director Apr 30 '25 Sale 129.66 2,600 337,116 34,058 May 02 05:04 PM SALLY E BLOUNT Director Apr 30 '25 Proposed Sale 129.66 2,600 337,116 Apr 30 04:23 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 06 '25 Option Exercise 80.98 91,167 7,382,704 163,095 Mar 07 06:55 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 07 '25 Option Exercise 80.98 200 16,196 72,128 Mar 07 06:55 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 06 '25 Sale 133.82 91,167 12,199,968 71,928 Mar 07 06:55 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 07 '25 Sale 136.65 200 27,329 71,928 Mar 07 06:55 PM Lisa D. Earnhardt Officer Mar 07 '25 Proposed Sale 136.65 200 27,329 Mar 07 06:28 PM Lisa D. Earnhardt Officer Mar 06 '25 Proposed Sale 133.82 91,167 12,199,967 Mar 06 05:47 PM Wainer Andrea F RETIRED EVP Mar 03 '25 Sale 138.17 949 131,123 74,381 Mar 04 08:05 PM Shroff Eric Senior Vice President Mar 03 '25 Sale 138.17 562 77,652 31,970 Mar 04 08:00 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Mar 03 '25 Sale 138.17 1,111 153,507 66,878 Mar 04 07:49 PM Moreland Mary K EXECUTIVE VICE PRESIDENT Mar 03 '25 Sale 138.17 791 109,292 95,583 Mar 04 07:44 PM MCCOY JOHN A. JR. VICE PRESIDENT AND CONTROLLER Mar 03 '25 Sale 138.17 562 77,652 21,061 Mar 04 07:39 PM Eric Shroff Officer Mar 03 '25 Proposed Sale 138.17 562 77,651 Mar 03 08:40 PM Andrea F. Wainer Retired Officer Mar 03 '25 Proposed Sale 138.17 949 131,123 Mar 03 08:18 PM Louis H. Morrone Officer Mar 03 '25 Proposed Sale 138.17 1,111 153,506 Mar 03 08:08 PM Mary K. Moreland Officer Mar 03 '25 Proposed Sale 138.17 791 109,292 Mar 03 07:58 PM John A. McCoy, Jr. Officer Mar 03 '25 Proposed Sale 138.17 562 77,651 Mar 03 07:52 PM Ford Robert B CHAIRMAN AND CEO Feb 05 '25 Option Exercise 38.40 285,388 10,958,899 505,447 Feb 07 05:51 PM Ford Robert B CHAIRMAN AND CEO Feb 05 '25 Sale 131.17 285,388 37,435,200 220,059 Feb 07 05:51 PM Robert B. Ford Officer Feb 05 '25 Proposed Sale 131.17 285,388 37,435,238 Feb 05 06:52 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 29 '25 Option Exercise 38.40 131,360 5,044,224 316,166 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 30 '25 Option Exercise 38.40 58,428 2,243,635 243,234 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 29 '25 Sale 128.35 131,360 16,859,675 184,806 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 30 '25 Sale 128.07 58,428 7,482,629 184,806 Jan 31 07:16 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Jan 30 '25 Option Exercise 38.40 23,771 912,806 149,468 Jan 31 07:08 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Jan 30 '25 Sale 128.50 23,771 3,054,574 125,697 Jan 31 07:08 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Jan 28 '25 Sale 127.39 2,644 336,819 0 Jan 30 07:33 PM Hubert L. Allen Officer Jan 30 '25 Proposed Sale 128.07 58,428 7,482,628 Jan 30 05:33 PM Daniel Gesua Sive Salvadori Officer Jan 30 '25 Proposed Sale 128.50 23,771 3,054,573 Jan 30 05:26 PM Hubert L. Allen Officer Jan 29 '25 Proposed Sale 128.35 131,360 16,859,675 Jan 29 05:30 PM Funck, Jr. Robert E. Officer Nov 04 '24 Proposed Sale 120.00 15,000 1,800,000 Nov 04 04:02 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Oct 21 '24 Option Exercise 47.00 157,421 7,398,787 342,227 Oct 23 05:10 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Oct 21 '24 Sale 117.04 157,421 18,424,298 184,806 Oct 23 05:10 PM ALLEN HUBERT L Officer Oct 21 '24 Proposed Sale 118.89 157,421 18,715,783 Oct 21 04:08 PM Ford Robert B CHAIRMAN AND CEO Sep 12 '24 Option Exercise 47.19 141,679 6,685,975 361,738 Sep 13 05:24 PM Ford Robert B CHAIRMAN AND CEO Sep 12 '24 Sale 116.41 141,679 16,493,218 220,059 Sep 13 05:24 PM Robert B. Ford Officer Sep 12 '24 Proposed Sale 116.41 141,679 16,492,852 Sep 12 06:20 PM MCCOY JOHN A. JR. VICE PRESIDENT Sep 04 '24 Sale 114.83 27 3,100 18,681 Sep 04 07:52 PM Funck, Jr. Robert E. Officer Sep 04 '24 Proposed Sale 115.00 30,000 3,450,000 Sep 04 04:04 PM